1. OS08.8.A Integrin-specific CAR T cells for the treatment of glioblastoma. (5th September 2022) Authors: Villars, D; Hänsch, L; Silginer, M; Weiss, T; Weller, M; Roth, P Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 2 Page Start: ii20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P04.11 Profound sensitivity of glioblastoma cells to apoptosis induction by TG02, a novel oral multi-cyclin-dependent kinase inhibitor. (19th September 2018) Authors: Le Rhun, E; von Achenbach, C; Lohmann, B; Silginer, M; Schneider, H; Meetze, K; Szabo, E; Weller, M Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii280 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P04.11 Profound sensitivity of glioblastoma cells to apoptosis induction by TG02, a novel oral multi-cyclin-dependent kinase inhibitor. (19th September 2018) Authors: Le Rhun, E; von Achenbach, C; Lohmann, B; Silginer, M; Schneider, H; Meetze, K; Szabo, E; Weller, M Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii280 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P10.19.B An immunotoxin targeting CD317 for the treatment of glioblastoma. (5th September 2022) Authors: Gramatzki, D; Weiss, T; Hänsch, L; Silginer, M; Rushing, E J; Roth, P; Gramatzki, M; Peipp, M; Weller, M Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 2 Page Start: ii53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P10.20.A Mechanisms of synergistic glioma growth suppression by radiotherapy and MET inhibition. (5th September 2022) Authors: Silginer, M; Papa, E; Szabo, E; Vasella, F; Pruschy, M; Stroh, C; Roth, P; Weiss, T; Weller, M Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 2 Page Start: ii53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PL03.3.A Development and characterization of CD317-specific CAR T cells as an innovative immunotherapeutic strategy against glioblastoma. (9th September 2021) Authors: Hänsch, L; Peipp, M; Myburgh, R; Silginer, M; Weiss, T; Gramatzki, D; Vasella, F; Manz, M; Weller, M; Roth, P Journal: Neuro-oncology Issue: Volume 23: Supplement 2 (2021) Page Start: ii2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗